[Replay now available!] Each Hour Counts: The Clinical and Economic Case for Rapid Sepsis Diagnostics

Attend this presentation by our expert panel and learn how your institution can improve patient outcomes, healthcare costs and antimicrobial stewardship with rapid molecular diagnostics.

Featured Speakers:

• Michael Saubolle, Ph.D., D(ABMM), F(AAM), F(IDSA), Medical Director, Infectious Diseases Division, Laboratory Sciences of Arizona
• Bert Lopansri, M.D., Associate Professor of Medicine, Division of Infectious Diseases, Intermountain Medical Center
• Melissa B. Miller, Ph.D., D(ABMM), Associate Professor, Pathology & Laboratory Medicine Director, Clinical Molecular Microbiology Lab

Sepsis is the most expensive condition to treat in the U.S. and is one of the deadliest diseases. Delayed identification of the causative bacterium and associated antimicrobial resistance can hinder effective treatment and worsen patient outcomes. Rapid identification of these pathogens provides vital information for clinicians to determine the best treatment for their patients.

This complimentary webinar gives an in-depth look at outcomes studies that have measured the clinical and economic benefits achieved through implementation of rapid sepsis diagnostics.